• 1. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 2. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 3. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
• 4. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

4-(4'-(2-Pentyloxy)phenyl)phenylboronic Acid: A Versatile Compound in Modern Pharmaceutical Research

4-(4'-(2-Pentyloxy)phenyl)phenylboronic Acid (CAS No. 1072951-79-1) has emerged as a critical component in the development of advanced pharmaceutical formulations due to its unique molecular structure and functional properties. This compound belongs to the class of boronic acid derivatives, which are widely utilized in drug discovery and biological conjugation applications. The presence of a boronic acid group in its chemical structure allows for specific interactions with diol-containing molecules, making it a valuable tool in the design of targeted drug delivery systems and prodrug strategies.

Recent studies have highlighted the potential of 4-(4'-(2-Pentyloxy)phenyl)phenylboronic Acid in enhancing the bioavailability of therapeutic agents. A 2023 publication in Advanced Drug Delivery Reviews demonstrated that the 2-pentyloxy group contributes to the solubility and stability of the compound in aqueous environments, which is crucial for oral drug formulations. The phenylboronic acid moiety further enables the compound to act as a cross-linking agent in the development of polymer-based drug carriers, offering improved controlled release profiles.

The 4-(4'-(2-Pentyloxy)phenyl)phenylboronic Acid structure is characterized by the presence of two aromatic rings connected through a boronic acid linkage. The 2-pentyloxy substituent on the para-position of the phenyl ring introduces hydrophobicity, while the boronic acid group provides functional reactivity. This dual functionality makes the compound particularly suitable for applications in biomaterials science and nanomedicine, where precise molecular interactions are essential.

Research published in Journal of Medicinal Chemistry in 2024 has explored the role of 4-(4'-(2-Pentyloxy)phenyl)phenylboronic Acid in antioxidant drug design. The compound's ability to form stable complexes with hydroxyl radicals has been linked to its potential as a radical scavenger in therapeutic contexts. This property is particularly relevant for the development of anti-inflammatory agents and <

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)